Abstract:Esophageal Squamous Cell Carcinoma (ESCC) is the predominant type of Esophageal Cancer (EC), accounting for nearly 88% of EC incidents worldwide. Importantly, it is also a life-threatening cancer for patients diagnosed in advanced stages, with only a 20% 5-year survival rate due to a limited number of actionable targets and therapeutic options. Increasing evidence has shown that inter-tumor and intra-tumor heterogeneity are widely distributed across ESCC tumor tissues. In our work, multi-omics data from ESCC cell lines, tumor tissue, normal tissue and Patient-Derived Xenograft (PDX) tissues were analyzed to investigate the heterogeneity among ESCC samples at the DNA, RNA, and protein level. We identified enrichment of ECM-receptor interaction and Focal adhesion pathways from the subset of protein-coding genes with non-silent mutations in ESCC patients. We also found that TP53, TTN, KMT2D, CSMD3, DNAH5, MUC16 and DST are the most frequently mutated genes in ESCC patient samples. Out of the identified genes, TP53 is the most frequently mutated, with 84 distinct non-silent mutation variants. We observed that p.R248Q, p.R175G/H, and p.R273C/H are the most common TP53 mutation variants. The diversity of TP53 mutations reveal its importance in ESCC progression and may also provide promising targets for precision therapeutics. Additionally, we identified the Olfactory transduction as the top signaling pathway, enriched from genes uniquely expressed in The Cancer Genome Atlas (TCGA)-ESCC patient tumor tissues, which may provide implications for the exact roles of the corresponding genes in ESCC. Cyclic nucleotide-gated channel subunit beta 1(CNGB1), a gene belonging to the Olfactory transduction pathway, was found exclusively overexpressed in ESCC. Expression of CNGB1 could serve as a marker, indicating potential diagnostic or therapeutic value. Finally, we investigated heterogeneity in the context of the ESCC PDX model, which is an emerging tool used to predict drug response and recapitulate tumor behavior in vivo. We observed trans-species heterogeneity in as high as 75% of the identified proteins, indicating that the ambiguity of proteins should be addressed by specific strategies to avoid drawing false conclusions. The identification and characterization of gene mutation and expression heterogeneity across different ESCC datasets, including various novel TP53 mutations, ECM-receptor interaction, Focal adhesion, and Olfactory transduction pathways (CNGB1), provide researchers with evidence and implications for accurate research and precision therapeutic development.

Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer

Multi-omics based artificial intelligence for cancer research

Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma

Single-cell multi-omics sequencing and its application in tumor heterogeneity.

Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration

Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches

Current advances on single or multi-omics analysis of esophageal cancer

Artificial Intelligence-Based Multi-Omics Analysis Fuels Cancer Precision Medicine.

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

The burgeoning spatial multi-omics in human gastrointestinal cancers

Editorial: Application of multi-omics analysis in thoracic cancer immunotherapy

Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing

Research and application of omics and artificial intelligence in cancer

Clinical significance of heterogeneity in multifocal hepatocellular carcinoma:A multi-omics study

Abstract 6270: Integrating spatial transcriptomics and single-cell RNA-seq reveal the tumorigenesis and heterogeneity of esophageal squamous cell carcinoma

Tumor Heterogeneity in Gastrointestinal Cancer Based on Multimodal Data Analysis

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

A survey on multi-omics-based cancer diagnosis using machine learning with the potential application in gastrointestinal cancer